Here’s my… foreword to the Romney Hythe and Dymchurch Railway guidebook

December 20th, 2013 by Ben Goldacre in bad science | 3 Comments »

I often tweet about my love for the RH&D narrow gauge railway, and this year they asked me to write an introduction for their guidebook. Some of the staff were worried by what I sent. But they were wrong. I love this railway. Here’s the piece. Read the rest of this entry »

FREE! Here is the new “What Happened Next?” update chapter from Bad Pharma 2013

December 19th, 2013 by Ben Goldacre in bad science | 1 Comment »

20130923_200935-MOTIONHere is the extra update chapter from the new 2013 paperback edition of Bad Pharma. It’s a fun romp through the changes that have happened over the past year or so, starring the many ethical professionals in pharma and medicine who have tried to push things forward, and some very shameful denialism from people in positions of “leadership”. There are some very interesting imperfections in medicine, they cost lives, and they can all be easily fixed, where there is common sense and good-will.

It’s all much more fun if you’ve read the book itself. As always, if you like what I do, and want me to do more: buy my books and give them to your friends. Apart from anything else, it scares the enemy. You can find Bad Pharma here on…

… Amazon ……….

…….. Waterstones ……

……………… or Hive.

So, here Read the rest of this entry »

RandomiseMe: our fun new website that lets anyone design and run a randomised controlled trial.

December 16th, 2013 by Ben Goldacre in bad science | 1 Comment »

Screenshot 2013-12-16 14.46.15Catching up and blogging this year’s activities: here’s a fun website I made with my friend Carl Reynolds, fellow doctor behind NHS HackDays (where nerds who love the NHS build useful tools). RandomiseMe lets you design and run randomised controlled trials, either on yourself, or on your friends. You can do a trial to see if your new trainers let you run faster than your old ones, find out if cheese gives you nightmares, or club together with friends and work out which kind of gloopy abdomen baste is best at preventing stretch marks in pregnancy.  Read the rest of this entry »

Why – and how – I wrote Bad Pharma

October 8th, 2013 by Ben Goldacre in bad science | 21 Comments »

This is my piece for Waterstones Book Club, where I was asked to write about why – and how – I wrote Bad Pharma. The full book club caboodle is here, and you can buy the book here.

Here it is… Read the rest of this entry »

I totally just walked past a tube advert for my book.

October 3rd, 2013 by Ben Goldacre in bad science | 3 Comments »

You might not find this as weird as I do, but I totally just walked past a tube advert for my book. SO: there’s a lovely new edition of Bad Pharma out this month, with a spanking extra chapter about all the bad things that naughty people like the ABPI and EFPIA have done in campaigning against trials transparency, and all the good things that lovely people like the BMA and EMA have done to advance the cause of patient safety. More to come on all this, but until then: here’s an unnecessary animated gif of me tooling around, via a baffled tourist on the platform.

20130923_200935-MOTION

Head-to-Head with PhRMA on transparency in the BMJ

July 12th, 2013 by Ben Goldacre in alltrials campaign, bad science, publication bias | 2 Comments »

This week in the BMJ there’s a head-to-head on trials transparency between me and PhRMA, the pharmaceutical industry representative body in the US. My article is here, PhRMA’s is here, both articles are open access for one week (since it was press released, them’s the rules at the BMJ…) but mine is open access forever, I think, on this link.

The article from PhRMA is remarkable. Firstly, they imply that people like me, who call for all trial results to be reported, also somehow call for the reckless disclosure of individual patients’ electronic health records online. This is untrue.

More disturbing is PhRMA’s suggestion that the problem has already been fixed. For example, John Castellani says that “information on clinical trials for potential new medicines is already required by US law to be posted on ClinicalTrials.gov“. As I explain in my piece, the best available published evidence on compliance with this law comes from Prayle et al, BMJ 2012: in reality, the legislation here has been very widely ignored.

We need to fix the problem of withheld results. Doctors (and patients, and researchers, and payers, and the public) need access to all the results, of all the trials, on all the uses, of all the treatments currently being prescribed, in order to make informed decisions about which is best.

More in the articles, and for even more on why this matters for patient care, I recommend the first chapter of Bad Pharma.

Enjoy!

www.bmj.com/content/347/bmj.f1881

www.bmj.com/content/347/bmj.f1880?ijkey=KJaN2gQyuYf46yS&keytype=ref

 

Badger badger badger badger CULL badger badger badger TRIAL

June 1st, 2013 by Ben Goldacre in bad science | 13 Comments »

Reading about the badger cull today, I noticed this column – on the evidence for badger culls – never got posted. Here it is!

Ben Goldacre, The Guardian, Saturday 23 July 2011

Squabbles between farmers and animal rights’ protesters bore me senseless. This week, environment secretary Caroline Spelman announced that the scientific evidence supports her new policy of farmers killingbadgers to prevent bovine TB. It’s an overstatement, but more importantly, this story walks through several important issues in science. Read the rest of this entry »

Why is Imperial College permitting Westminster public school to sell an internship?

May 14th, 2013 by Ben Goldacre in bad science, just a blog | 11 Comments »

This is very odd indeed. Westminster, one of the most expensive public schools in the UK, is holding a fund-raising auction. In this auction, you can buy an internship at Imperial College’s Institute of Biomedical Engineering, on the promise that this will look great on your CV. Read the rest of this entry »

My evidence to the Science and Tech Select Committee inquiry on missing trial data

April 26th, 2013 by Ben Goldacre in alltrials campaign, bad science, big pharma | 6 Comments »

The UK House of Commons Science and Technology Select Committee are currently looking at the problem of clinical trial results being withheld from doctors and patients (partly, the committee says, in response to Bad Pharma, which is heartening). A clear, thoughtful report and policy recommendations from this committee could be an important step towards fixing these problems.

I gave oral evidence this week on a panel with Roche, GSK, and the ABPI (who have previously tried to pretend that all the issues in Bad Pharma were “historic” and “long addressed”). I’ve posted the video below, and I’ve posted my written evidence underneath that. First is my submission addressing the specific questions posed by the Committee, and then my appendix, giving background on the problem of withheld trial results. Read the rest of this entry »

How vaccine scares respect local cultural boundaries.

April 24th, 2013 by Ben Goldacre in africa, bad science, book, MMR | 17 Comments »

I was on Newsnight this evening, discussing the measles outbreak in Swansea, and how we can get people vaccinated with MMR when they’ve previously refused. In my view: prevention is better than cure, it’s hard to reverse a scare story once the toothpaste is out of the tube, and we must innoculate ourselves against future vaccine scares, because they will come. That’s why services like Behind The Headlines are important. Here’s the video:

www.bbc.co.uk/iplayer/episode/b01s5bn7/Newsnight_24_04_2013/

At the end, Jeremy Paxman seemed (endearingly) amazed to hear that vaccine scares respect local cultural boundaries. Here’s what I was discussing, in an extract from my first book Bad Science (this bit’s from pages 292-4 of the red paperback):

Read the rest of this entry »